Home | RX Summit
Release Date: March 22, 2019
Announcements
Coming Soon: Rx Drug Abuse & Heroin Summit
The Rx Drug Abuse & Heroin Summit convenes a national collaboration of stakeholders from Federal to family to discuss what’s working in opioid overdose prevention and treatment. Be part of the international discussion on addressing the opioid crisis at the 2019 Rx Drug Abuse & Heroin Summit April 22-25, 2019 in Atlanta. https://www.rx-summit.com/
Opioid Response Notice of Funding Opportunity
CDC recently released the “Overdose Data to Action” (RFA-CE19-1904) Notice of Funding Opportunity (NOFO) which focuses on the complex and changing nature of the opioid overdose epidemic. These funds will support state, territorial, and select county, city, or township health departments in obtaining high quality, comprehensive, and timely data on overdose morbidity and mortality and using those data to inform prevention and response efforts.
This three-year funding opportunity will continue work focused on increasing comprehensiveness and timeliness of surveillance data; building state and local capacity for public health programs determined to be promising based on research evidence; making prescription drug monitoring programs easier to use and access; and working with health systems, insurers, and communities to improve opioid prescribing. It adds new work that is focused on linkages to care and other areas of innovation supported by evidence-based practice.
Applications are due May 2, 2019. For specific details, visit our webpage or the related documents section of the notice online atgrants.gov.
Recent Articles and Publications
The reduction of opioid prescribing that began in 2012 has accelerated in the United States. This report analyzed opioid prescribing at the county-level in 2015 and 2017. The amount of opioids prescribed in the U.S. decreased an average of 10% annually with reductions in 74.7% of counties from 2015 to 2017. Despite reductions in prescribing, opioids continue to be prescribed at nearly triple the amount prescribed in 1999. Furthermore, we know from other reports that opioid overdoses continue to increase, driven largely by illicitly manufactured fentanyl. Coordination across multiple sectors, including public health, health care, and public safety can reduce the burden of the opioid overdose epidemic.
An average of 233.7 million opioid prescriptions were filled each year in the United States between 2006 and 2017. This report analyzed trends and patterns in opioid prescribing practices by state. Despite reductions in four of the six key opioid prescribing measures in the U.S., the average duration of all prescriptions dispensed and the rate of long-term (≥ 30 days) prescriptions increased. At the state level, awareness of their opioid prescribing trends and measures could help officials modify and expand their opioid prevention and treatment programs through legislation, regulations, enforcement, surveillance and education.
Fentanyl was involved in almost 1,600 drug overdose deaths each year in 2011 and 2012, but from 2012 through 2014, the number of drug overdose deaths involving fentanyl more than doubled each year. This report shows the rise in drug overdose deaths involving fentanyl from 2011 through 2016 nationally, and by age, sex, race and ethnicity, and public health region. Drug overdose deaths involving fentanyl increased from 1,663 in 2011 to 18,335 in 2016. Understanding national trends and patterns for drug overdose deaths involving fentanyl may inform public health policies and practices.
No hay comentarios:
Publicar un comentario